FDA performance goals for approving drugs and biologics

James Dabney Miller

doi:10.1001/jama.2009.974

FDA performance goals for approving drugs and biologics

James Dabney Miller

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	189-191
Number of pages	3
Journal	JAMA
Volume	302
Issue number	2
DOIs	https://doi.org/10.1001/jama.2009.974
State	Published - Jul 8 2009

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1001/jama.2009.974

Cite this

@article{60cf50f3f90c4327b8a3f6a9b3a0c95b,

title = "FDA performance goals for approving drugs and biologics",

author = "Miller, {James Dabney}",

year = "2009",

month = jul,

day = "8",

doi = "10.1001/jama.2009.974",

language = "English (US)",

volume = "302",

pages = "189--191",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "2",

}

TY - JOUR

T1 - FDA performance goals for approving drugs and biologics

AU - Miller, James Dabney

PY - 2009/7/8

Y1 - 2009/7/8

UR - http://www.scopus.com/inward/record.url?scp=67650123123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650123123&partnerID=8YFLogxK

U2 - 10.1001/jama.2009.974

DO - 10.1001/jama.2009.974

M3 - Comment/debate

C2 - 19584348

AN - SCOPUS:67650123123

SN - 0098-7484

VL - 302

SP - 189

EP - 191

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 2

ER -

FDA performance goals for approving drugs and biologics

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this